KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $36.77 $57.07 Friday, 26th Apr 2024 BHVN stock ended at $38.97. This is 1.12% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 4.05% from a day low at $37.75 to a day high of $39.28.
90 days $36.77 $62.21
52 weeks $12.37 $62.21

Historical Biohaven Pharmaceutical Holding Company Ltd prices

Date Open High Low Close Volume
Apr 26, 2024 $38.61 $39.28 $37.75 $38.97 938 012
Apr 25, 2024 $38.95 $38.95 $36.77 $38.54 1 825 113
Apr 24, 2024 $40.19 $40.62 $38.38 $38.72 948 329
Apr 23, 2024 $40.54 $41.88 $39.25 $39.61 2 087 103
Apr 22, 2024 $39.70 $39.70 $38.19 $38.33 1 072 874
Apr 19, 2024 $42.36 $43.24 $37.61 $38.99 3 353 103
Apr 18, 2024 $42.90 $43.31 $41.00 $42.16 3 607 532
Apr 17, 2024 $44.14 $45.60 $42.55 $44.03 930 066
Apr 16, 2024 $44.77 $45.07 $42.35 $43.77 1 917 088
Apr 15, 2024 $50.96 $52.50 $43.58 $44.77 3 208 915
Apr 12, 2024 $53.49 $53.70 $52.13 $53.08 774 543
Apr 11, 2024 $51.53 $53.80 $51.20 $53.49 675 149
Apr 10, 2024 $50.37 $51.60 $49.77 $51.06 708 374
Apr 09, 2024 $51.62 $53.13 $50.85 $51.98 650 826
Apr 08, 2024 $52.29 $52.33 $50.02 $51.41 756 088
Apr 05, 2024 $51.93 $53.73 $51.36 $52.52 574 891
Apr 04, 2024 $52.70 $55.69 $51.60 $52.33 879 258
Apr 03, 2024 $50.25 $52.73 $50.25 $52.28 771 860
Apr 02, 2024 $50.99 $52.15 $50.10 $50.79 953 828
Apr 01, 2024 $54.69 $54.69 $51.60 $52.06 935 873
Mar 28, 2024 $57.02 $57.02 $54.65 $54.69 821 546
Mar 27, 2024 $56.88 $57.07 $54.22 $57.02 812 001
Mar 26, 2024 $58.20 $59.53 $56.20 $56.29 1 347 102
Mar 25, 2024 $55.62 $56.32 $55.20 $55.23 1 128 668
Mar 22, 2024 $55.63 $56.43 $55.25 $55.85 529 153
Click to get the best stock tips daily for free!

About Biohaven Pharmaceutical Holding Company Ltd

Biohaven Pharmaceutical Holding Company Ltd Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavegepant that is in phase III clinical trials for acute and preventive treatment of migraine, as well as re... BHVN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT